First Trust Nyse Arca Biotechnology Index Fund ETF News

Smart Beta ETF report for FBT

FBT doesn't pay any dividend and had a negative price growth over the short term. Barring the inverse funds, all other biotechnology ETFs had a high negative growth over the past 12 months.

Sector ETF report for FBT

Smart Beta ETF report for FBT

FBT is a passive biotechnology ETF, which doesn't pay any dividend. Baring the past one year, FBT's price return has outperformed the S&P 500.

Sector ETF report for FBT

Smart Beta ETF report for FBT

In trading on Thursday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (Symbol: FBT) crossed above their 200 day moving average of $165.63, changing hands as high as $166.36 per share. First Trust NYSE Arca Biotechnology Index Fund shares are currently trading up about 1% on the day. The chart below shows [] The post FBT Makes Bullish Cross Above Critical Moving Average appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

Biotech ETFs was the biggest gainer last week.

Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.

Sector ETF report for FBT

Smart Beta ETF report for FBT

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.